Table 1.
Ep-CAM expression | |||||
Variable | Patients | 0 | 1+ | 2+ | 3+ |
Patients | 15 | 18 | 8 | 29 | |
Male | 50 (71) | 10 (67) | 12 (67) | 5 (38) | 23 (79) |
Female | 20 (29) | 5 (33) | 6 (33) | 3 (62) | 6 (21) |
Primary Tumor | |||||
pT1 | 15 (21) | 4 (27) | 3 (17) | 3 (38) | 5 (17) |
pT2 | 11 (16) | 3 (20) | 2 (11) | 2 (24) | 4 (14) |
pT3 | 42 (60) | 8 (53) | 11 (61) | 3 (38) | 20 (69) |
pT4 | 2 (3) | 0 (0) | 2 (11) | 0 (0) | 0 (0) |
Lymph node status | |||||
pN0 | 33 (47) | 7 (47) | 9 (50) | 6 (75) | 11 (38) |
pN1 | 37 (53) | 8 (53) | 9 (50) | 2 (25) | 18 (62) |
Tumor grade | |||||
G2 | 47 (67) | 10 (67) | 12 (67) | 6 (75) | 19 (66) |
G3 | 23 (33) | 5 (33) | 6 (33) | 2 (25) | 10 (34) |
*No statistical significant correlations between Ep-CAM expression and the histopathological parameters were observed.